Category: pricefixing
-
Teva settles further price-fixing lawsuits in the US
•
Teva Pharmaceutical Industries (TSX: TEVA, NYSE: TEVA) has settled another lawsuit alleging price-fixing in the United States. Teva will pay $450 million in court-approved settlements in the United States, one for $425 million and the other for $25 million, without admitting any wrongdoing. The settlement amounts will be distributed over…